Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
Hyemin Jeong, Yeong Hee Eun, In Young Kim, Hyungjin Kim, Joong Kyong Ahn, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha
Korean J Intern Med. 2018;33(2):407-416.   Published online 2016 Oct 12     DOI: https://doi.org/10.3904/kjim.2016.042
Citations to this article as recorded by Crossref logo
Reactions Weekly.2018; 1698(1): 21.     CrossRef
Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
Philip J. Mease, Désirée van der Heijde, Chitra Karki, Mei Liu, Yujin Park, Jeffrey D. Greenberg
Rheumatology and Therapy.2018; 5(2): 537.     CrossRef
Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis
Atul Deodhar, David Yu
Seminars in Arthritis and Rheumatism.2017; 47(3): 343.     CrossRef
Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis
Hai Lin, Yi-Zhen Gong
Rheumatology International.2017; 37(8): 1267.     CrossRef